Back to Schemes

Mitochondrial DNA disorders

Product Code: 01-MTD-27

From £467.00

Deadline to order: 30/11/2026

Testing for variants in the mitochondrial genome for the following mitochondrial disorders: MELAS, NARP, LHON, MERRF, Leigh syndrome, and Pearson syndrome.

Target/Genes:

Variants in mtDNA (mitochondrial genome). Mitochondrial disorders which MAY be covered by the EQA scheme include MELAS, NARP, LHON, MERRF, Leigh syndrome, and Pearson syndrome. Levels of homo/heteroplasmy will be assessed.

Technology:

CNV, MLPA, NGS, PCR based

Language:

English, French, German, Italian, Spanish

Sample Type:

DNA (in TE Buffer)

Accredited:

Yes

Sample dispatch to your laboratory:

Jan-27

Test and Submit Results:

January - March 2027 (for exact dates, please see scheme instructions)

Final Results and Certificate:

 August 2027

You can complete purchase on our secure partner site.

How it works

Register

  • Enrol before the closing date (30/11/2026)
  • EMQN ships EQA samples or digital cases

Test & submit results

  • Analyse samples in your routine workflow
  • Upload results via your website account (January - March 2027 (for exact dates, please see scheme instructions))

Review & get certified

  • EMQN assesses your data
  • Receive your individual results, EQA summary report & certificate of participation ( August 2027)

EQA Assessment

The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy. If your laboratory does not provide clinical interpretation, supporting information must be uploaded explaining the reason for this.

Sample Details

Three mock clinical cases: 2 with matching samples and 1 virtual case will be provided.

Approximately 2µg DNA per sample is provided. Complete information will be available in scheme instructions.

EQA Results

Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.

Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

Participation Information

Participants are expected to test samples according to their routine strategy, to return a clinical report and to complete the data collection form.

Laboratories are expected to provide information about the technical and clinical limitations of their assays. Levels of homo/heteroplasmy will be assessed.

No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).

Enquire about this scheme

Contact Information

added wishlist!
View Wishlist

0

View Wishlist

Register Interest

Express your interest in ''.